Search - tctmd.com

Displaying 81 - 100 of 279

Sort: Relevancy | Date

News Conference News TCT 2019

‘Spooky’ Signal Still Haunts Paclitaxel DCBs in PAD, but Updated Analysis Reassures

L.A. McKeown

September 28, 2019

News Conference News HFSA 2019

DEFINE-HF: Dapagliflozin Improves Function and QoL, but Not Biomarkers, in HFrEF

L.A. McKeown

September 16, 2019

News Conference News ACC 2019

COAPT Quality-of-Life Analysis Points to Significant, Sustained Benefits in Health Status With MitraClip

Shelley Wood

March 17, 2019

News Conference News ACC 2019

CODIACS-QoL: Depression Screening in ACS Patients Fails to Boost Quality of Life

L.A. McKeown

March 16, 2019

News Daily News

AHA Scientific Statement: Get PAD Patients Moving to Improve Symptoms and QoL

L.A. McKeown

January 03, 2019

Attacking DVT With Drug-Device Combo Does Not Reduce Postthrombotic Syndrome

News Conference News VIVA 2018

VERNACULAR: A Novel Venous Stent Shows Promise for Treatment of Iliofemoral Occlusive Disease

L.A. McKeown

November 08, 2018

News Conference News TCT 2018

Transcatheter Mitral Valve Repair Provides Fast, Sustained Gains in Quality of Life

TCT Daily Staff

September 27, 2018

Presentation TCT 2018

PCI for Ischemia Part II: Why the ISCHEMIA Trial Might be Positive..or Negative!

Presenter: David J. Cohen, Sunil V. Rao, Ajay J. Kirtane

September 22, 2018

Presentation TCT 2018

PCI for Ischemia Part I: Critical Analysis of the FAME Trials and ORBITA

Presenter: David J. Cohen, Sunil V. Rao, Bernard J. Gersh

September 22, 2018

Presentation TCT 2018

Increasing Emphasis on QOL Outcomes: From Patient Preference to Instrument Validation

Presenter: David J. Cohen, Sunil V. Rao, John A. Spertus

September 22, 2018

Presentation TCT 2018

Optimal Medical Therapy With and Without Coronary Revascularization: Which Drugs Matter? Symptoms, Ischemia, or Prognosis? And Magnitude of Impact

Presenter: David J. Cohen, Sunil V. Rao, David J. Maron

September 22, 2018

Podcast TCTMD Talking Points

Quality of Life After PCI vs CABG in Left Main CAD: EXCEL

July 18, 2018

News Conference News EuroPCR 2018

ORBITA Deep Dive Highlights Treatment Choices, Social Media, and Ethics

Michael O'Riordan

May 31, 2018

News Daily News

RANGER-SFA Data Support Another Paclitaxel-Coated Balloon for Superficial Femoral Artery Disease

L.A. McKeown

May 08, 2018

Presentation TCTAP 2018

DECISION-CTO: Updated QOL and Long-Term Outcomes

Presenter: Seung-Whan Lee

April 28, 2018

News Conference News SCAI 2018

Heart Function, QoL Improvements at 1 Year in US Postapproval MitraClip Registry: PAS-1

Shelley Wood

April 27, 2018

News Conference News SCAI 2018

PERSPECTIVE: Contemporary Technique and Practice Confer Clinical Success and QoL Benefit for CTO PCI

L.A. McKeown

April 26, 2018

News Daily News

Early Invasive Strategy Linked to Worse QoL in Elderly NSTEMI Patients

L.A. McKeown

January 23, 2018

News Daily News

EVAR Shown to IMPROVE Outcomes Over Surgery for Ruptured AAA Patients

L.A. McKeown

November 17, 2017

News Conference News TCT 2017

FAME 2 at 3 Years: Outcomes, Symptoms Better With PCI vs OMT in Stable CAD, at Similar Cost

L.A. McKeown

November 02, 2017

Advertisement

‘Spooky’ Signal Still Haunts Paclitaxel DCBs in PAD, but Updated Analysis Reassures

DEFINE-HF: Dapagliflozin Improves Function and QoL, but Not Biomarkers, in HFrEF

COAPT Quality-of-Life Analysis Points to Significant, Sustained Benefits in Health Status With MitraClip

CODIACS-QoL: Depression Screening in ACS Patients Fails to Boost Quality of Life

AHA Scientific Statement: Get PAD Patients Moving to Improve Symptoms and QoL

VERNACULAR: A Novel Venous Stent Shows Promise for Treatment of Iliofemoral Occlusive Disease

Transcatheter Mitral Valve Repair Provides Fast, Sustained Gains in Quality of Life

PCI for Ischemia Part II: Why the ISCHEMIA Trial Might be Positive..or Negative!

PCI for Ischemia Part I: Critical Analysis of the FAME Trials and ORBITA

Increasing Emphasis on QOL Outcomes: From Patient Preference to Instrument Validation

Optimal Medical Therapy With and Without Coronary Revascularization: Which Drugs Matter? Symptoms, Ischemia, or Prognosis? And Magnitude of Impact

Quality of Life After PCI vs CABG in Left Main CAD: EXCEL

ORBITA Deep Dive Highlights Treatment Choices, Social Media, and Ethics

RANGER-SFA Data Support Another Paclitaxel-Coated Balloon for Superficial Femoral Artery Disease

DECISION-CTO: Updated QOL and Long-Term Outcomes

Heart Function, QoL Improvements at 1 Year in US Postapproval MitraClip Registry: PAS-1

PERSPECTIVE: Contemporary Technique and Practice Confer Clinical Success and QoL Benefit for CTO PCI

Early Invasive Strategy Linked to Worse QoL in Elderly NSTEMI Patients

EVAR Shown to IMPROVE Outcomes Over Surgery for Ruptured AAA Patients

FAME 2 at 3 Years: Outcomes, Symptoms Better With PCI vs OMT in Stable CAD, at Similar Cost

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content